Stocks · Health care · Pharmaceutical Preparations

Immuneering Corp

IMRX Clue Score35
United States Fiscal year ends December CIK 0001790340 Results filed 29 Oct 2026

What the insiders did No buying or selling

By person

9 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Benjamin J. Zeskind
President and CEO
—
—
—
2,315,252
$10.56M
+1.5%
Brett Matthew Hall
Chief Scientific Officer
—
—
—
382,531
$1.74M
+10.6%
Peter Feinberg
Director
—
—
—
292,207
$1.33M
+28.6%
Thomas J. Schall
Director
—
—
—
74,530
$339.98K
+2,470%
Leah R Neufeld
Chief People Officer
—
—
—
29,598
$135.02K
+195.1%
Mallory Morales
SVP Finance, CAO
—
—
—
27,533
$125.60K
+116.2%
Harold Eugene Brakewood
Chief Business Officer
—
—
—
11,050
$50.41K
+183.3%
Diana Hausman
Director
—
—
—
5,500
$25.09K
—
Michael Bookman
Chief Legal Officer, Secretary
—
—
—
4,870
$22.22K
+26.5%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.